Search This Blog

Tuesday, June 25, 2019

AbbVie/Allergan deal may stoke buying in drug makers

Premarket buying has perked up in certain pharma firms on the news of AbbVie’s $188/share bid for Allergan.
Selected tickers: Teva Pharmaceutical Industries (NYSE:TEVA)(+4%), Endo International (NASDAQ:ENDP)(+5%), Perrigo (NYSE:PRGO)(+1%)
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)